Clinical practice guidelines for optimizing bone health in Korean children and adolescents

키워드

참고문헌 (67)

1. Ma NS, "Pediatric osteoporosis : where are we now?", J Pediatr, 161, pp.983~990 (2012)
2. Heaney RP, "Peak bone mass", Osteoporos Int, 11, pp.985~1009 (2000)
3. American Academy of Pediatrics Steering Committee on Quality Improvement and Management, "Classifying recommendations for clinical practice guidelines", Pediatrics, 114, pp.874~877 (2004)
4. Boot AM, "Peak bone mineral density, lean body mass and fractures", Bone, 46, pp.336~341 (2010)
5. Berger C, "Peak bone mass from longitudinal data : implications for the prevalence, pathophysiology, and diagnosis of osteoporosis", J Bone Miner Res, 25, pp.1948~1957 (2010)
6. Lim JS, "Bone mineral density according to age, bone age, and pubertal stages in Korean children and adolescents", J Clin Densitom, 13, pp.68~76 (2010)
7. Yi KH, "Reference values for bone mineral density according to age with body size adjustment in Korean children and adolescents", J Bone Miner Metab, 32, pp.281~289 (2014)
8. Golden NH, "Optimizing bone health in children and adolescents", Pediatrics, 134, pp.e1229~e1243 (2014)
9. Bishop N, "Fracture prediction and the definition of osteoporosis in children and adolescents : the ISCD 2013 Pediatric Official Positions", J Clin Densitom, 17, pp.275~280 (2014)
10. Root AW, "Pediatric endocrinology", pp.705~813 (2021), Elsevier
11. De Paula F, "William's textbook of endocrinology", pp.1256~1297 (2020), Elsevier
12. Imerci A, "Idiopathic juvenile osteoporosis : a case report and review of the literature", Int J Surg Case Rep, 9, pp.127~129 (2015)
13. Drake MT, "Primer on the metabolic bone diseases and disorders of mineral metabolism", pp.208~213 (2008), The American Society of Bone and Mineral Metabolism
14. Tritos NA, "Effects of growth hormome on bone", Prog Mol Biol Transl Sci, 138, pp.193~211 (2016)
15. Giustina A, "Growth hormone, insulin-like growth factors, and the skeleton", Endocr Rev, 29, pp.535~559 (2008)
16. Bassett JH, "Williams GR. Role of thyroid hormones in skeletal development and bone maintenance", Endocr Rev, 37, pp.135~187 (2016)
17. Sundaraghavan V, "Diabetes and bone health : latest evidence and clinical implications", Ther Adv Musculoskelet Dis, 9, pp.67~74 (2017)
18. Castrogiovanni P, "The importance of physical activity in osteoporosis. From the molecular pathways to the clinical evidence", Histol Histopathol, 31, pp.1183~1194 (2016)
19. Grover M, "Osteoporosis in children with chronic illness. Diagnosis, monitoring, and treatment", Curr Osteoporos Rep, 15, pp.271~282 (2017)
20. Compston J, "Glucocorticoid-induced osteoporosis : an update", Endocrine, 61, pp.7~16 (2018)
21. Henderson RC, "The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy", J Bone Miner Res, 25, pp.520~526 (2010)
22. Fehlings D, "Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis : a systematic review", Dev Med Child Neurol, 54, pp.106~116 (2012)
23. Hough JP, "Systematic review of interventions for low bone mineral density in children with cerebral palsy", Pediatrics, 125, pp.e670~e678 (2010)
24. Iwasaki T, "Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis", Curr Med Res Opin, 28, pp.737~747 (2012)
25. Rodd C, "Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation : a national observational study", Arthritis Care Res(Hoboken), 64, pp.122~131 (2012)
26. Vierucci F, "Osteoporosis in childhood", Curr Opin Rheumatol, 29, pp.535~546 (2017)
27. Schmidt S, "Low bone mineral density in children and adolescents with inflammatory bowel disease : a population-based study from Western Sweden", Inflamm Bowel Dis, 15, pp.1844~1850 (2009)
28. El-Matary W, "Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease", Dig Dis Sci, 56, pp.825~829 (2011)
29. Pappa H, "Skeletal health of children and adolescents with inflammatory bowel disease", J Pediatr Gastroenterol Nutr, 53, pp.11~25 (2011)
30. Hogler W, "Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia : comparison of fracture risk with the General Practice Research Database", Pediatr Blood Cancer, 48, pp.21~27 (2007)
31. Alos N, "High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy", J Clin Oncol, 30, pp.2760~2767 (2012)
32. Lalayiannis AD, "Assessing bone mineralisation in children with chronic kidney disease : what clinical and research tools are available?", Pediatr Nephrol, 35, pp.937~957 (2020)
33. Helenius I, "Incidence and predictors of fractures in children after solid organ transplantation : a 5-year prospective, population-based study", J Bone Miner Res, 21, pp.380~387 (2006)
34. Johnston CC Jr, "Calcium supplementation and increases in bone mineral density in children", N Engl J Med, 327, pp.82~87 (1992)
35. Lloyd T, "Calcium supplementation and bone mineral density in adolescent girls", JAMA, 270, pp.841~844 (1993)
36. Winzenberg TM, "Vitamin D supplementation for improving bone mineral density in children", Cochrane Database Syst Rev, (10), pp.CD006944~ (2010)
37. Greene DA, "Calcium and vitamin-D supplementation on bone structural properties in peripubertal female identical twins : a randomised controlled trial", Osteoporos Int, 22, pp.489~498 (2011)
38. "2020 Dietary reference intakes for Koreans: application"[URL]
39. Rosen CJ, "IOM committee members respond to Endocrine Society vitamin D guideline", J Clin Endocrinol Metab, 97, pp.1146~1152 (2012)
40. Holick MF, "Evaluation, treatment, and prevention of vitamin D deficiency : Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 96, pp.1911~1930 (2011)
41. Committee on Nutrition and the Council on Sports Medicine and Fitness, "Sports drinks and energy drinks for children and adolescents: are they appropriate?", Pediatrics, 127, pp.1182~1189 (2011)
42. Hind K, "Weight-bearing exercise and bone mineral accrual in children and adolescents : a review of controlled trials", Bone, 40, pp.14~27 (2007)
43. McKay HA, "Augmented trochanteric bone mineral density after modified physical education classes : a randomized schoolbased exercise intervention study in prepubescent and early pubescent children", J Pediatr, 136, pp.156~162 (2000)
44. MacKelvie KJ, "A school-based exercise intervention elicits substantial bone health benefits : a 2-year randomized controlled trial in girls", Pediatrics, 112, pp.e447~ (2003)
45. Petit MA, "A randomized school-based jumping intervention confers site and maturity-specific benefits on bone structural properties in girls : a hip structural analysis study", J Bone Miner Res, 17, pp.363~372 (2002)
46. Specker B, "Sudhagoni RG. Does exercise influence pediatric bone? A systematic review", Clin Orthop Relat Res, 473, pp.3658~3672 (2015)
47. Field AE, "Prospective study of physical activity and risk of developing a stress fracture among preadolescent and adolescent girls", Arch Pediatr Adolesc Med, 165, pp.723~728 (2011)
48. Hohman EE, "Dieting is associated with reduced bone mineral accrual in a longitudinal cohort of girls", BMC Public Health, 18, pp.1285~ (2018)
49. Baroncelli GI, "The use of bisphosphonates in pediatrics", Horm Res Paediatr, 82, pp.290~302 (2014)
50. Dwan K, "Bisphosphonate therapy for osteogenesis imperfecta", Cochrane Database Syst Rev, 10, pp.CD005088~ (2016)
51. Alcausin MB, "Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of age", Horm Res Paediatr, 79, pp.333~340 (2013)
52. Baroncelli GI, "Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis : comparison with untreated patients", J Bone Miner Metab, 31, pp.533~543 (2013)
53. Bachrach LK, "Clinical review 1 : bisphosphonate use in childhood osteoporosis", J Clin Endocrinol Metab, 94, pp.400~409 (2009)
54. Simm PJ, "Consensus guidelines on the use of bisphosphonate therapy in children and adolescents", J Paediatr Child Health, 54, pp.223~233 (2018)
55. Ozel S, "Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis : an update", Dev Med Child Neurol, 58, pp.918~923 (2016)
56. Iwasaki T, "Secondary osteoporosis in long-term bedridden patients with cerebral palsy", Pediatr Int, 50, pp.269~275 (2008)
57. Thornton J, "Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis", Arch Dis Child, 91, pp.753~761 (2006)
58. Acott PD, "Pamidronate treatment of pediatric fracture patients on chronic steroid therapy", Pediatr Nephrol, 20, pp.368~373 (2005)
59. El-Husseini AA, "Treatment of osteopenia and osteoporosis in renal transplant children and adolescents", Pediatr Transplant, 8, pp.357~361 (2004)
60. Sbrocchi AM, "Zoledronic acid for the treatment of osteopenia in pediatric Crohn's disease", Pediatr Int, 52, pp.754~761 (2010)
61. Gordon KE, "Impact of bisphosphonates on survival for patients with Duchenne muscular dystrophy", Pediatrics, 127, pp.e353~e358 (2011)
62. Sbrocchi AM, "The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy", Osteoporos Int, 23, pp.2703~2711 (2012)
63. 이재민, "Efficacy of pamidronate in children with low bone mineral density during and after chemotherapy for acute lymphoblastic leukemia and non-Hodgkin lymphoma", Blood Research, 48(2), pp.99~106 (2013), 대한혈액학회
64. Carpenter PA, "Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease", Biol Blood Marrow Transplant, 13, pp.683~690 (2007)
65. Suresh E, "Safety issues with bisphosphonate therapy for osteoporosis", Rheumatology(Oxford), 53, pp.19~31 (2014)
66. Khosla S, "Benefits and risks of bisphosphonate therapy for osteoporosis", J Clin Endocrinol Metab, 97, pp.2272~2282 (2012)
67. Makitie O, "Causes, mechanisms and management of paediatric osteoporosis", Nat Rev Rheumatol, 9, pp.465~475 (2013)